Detalhe da pesquisa
1.
Significance of glucocorticoid signaling in triple-negative breast cancer patients: a newly revealed interaction with androgen signaling.
Breast Cancer Res Treat
; 180(1): 97-110, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-31989378
2.
Impact of Topoisomerase IIα, PTEN, ABCC1/MRP1, and KI67 on triple-negative breast cancer patients treated with neoadjuvant chemotherapy.
Breast Cancer Res Treat
; 173(2): 275-288, 2019 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-30306430
3.
In breast cancer subtypes steroid sulfatase (STS) is associated with less aggressive tumour characteristics.
Br J Cancer
; 118(9): 1208-1216, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29563635
4.
Correction to: IRIS study: a phase II study of the steroid sulfatase inhibitor Irosustat when added to an aromatase inhibitor in ER-positive breast cancer patients.
Breast Cancer Res Treat
; 167(1): 407, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29071491
5.
The presence and impact of estrogen metabolism on the biology of triple-negative breast cancer.
Breast Cancer Res Treat
; 161(2): 213-227, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27848152
6.
IRIS study: a phase II study of the steroid sulfatase inhibitor Irosustat when added to an aromatase inhibitor in ER-positive breast cancer patients.
Breast Cancer Res Treat
; 165(2): 343-353, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-28612226
7.
How far have we come in terms of estrogens in breast cancer? [Review].
Endocr J
; 63(5): 413-24, 2016 May 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-27020038
8.
Interleukin (IL)-17A in triple-negative breast cancer: a potent prognostic factor associated with intratumoral neutrophil infiltration.
Breast Cancer
; 30(5): 748-757, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37178415
9.
Androgen Receptor Is a Non-canonical Inhibitor of Wild-Type and Mutant Estrogen Receptors in Hormone Receptor-Positive Breast Cancers.
iScience
; 21: 341-358, 2019 Nov 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-31698248
10.
Triple negative breast cancer chemosensitivity and chemoresistance: current advances in biomarkers indentification.
Expert Opin Ther Targets
; 20(6): 705-20, 2016 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-26607563